First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was formerly known as Biopharma Co., Inc. and changed its name to First Tracks Biotherapeutics, Inc. in February 2026. First Tracks Biotherapeutics, Inc. was incorporated in 2025 and is headquartered in San Diego, California. First Tracks Biotherapeutics, Inc. operates as a subsidiary of AnaptysBio, Inc.

La descripción de la empresa se muestra en inglés.

Estadísticas Clave

Capitalización: $782.20M
Ratio P/E: N/A
Máximo 52 Sem.: $26.80
Mínimo 52 Sem.: $14.79
Volumen Promedio: 265.53K

Datos proporcionados por Yahoo Finance a través de yfinance. Actualizado diariamente.

Información de la Empresa

Industria: Biotecnología
Bolsa: NASDAQ
País: United States